The 14th IAS Conference on HIV Science, IAS 2027, will take place in Geneva, Switzerland, 11-15 July 2027, as well as virtually. The organiser, the International AIDS Society (IAS), announced the dates and said around 5,000 people from 130 countries were expected to attend.
“IAS 2027 will bring together scientists, programme leaders, policy makers and communities in Geneva, long known as a hub for global health and human rights,” said IAS 2027 international co-chair and IAS president-elect Kenneth Ngure. “Together, we will take stock of the latest discoveries, chart progress in building and rebuilding research and programmes, and find the key to opening the door so that these tools reach everyone, everywhere.”
“Hosting IAS 2027 in Geneva at this critical time makes perfect sense,” added IAS 2027 local co-chair Alexandra Calmy, who heads the HIV Unit in the Division of Infectious Diseases at Geneva University Hospitals (HUG). “It will give us a solid platform for global collaboration in the HIV response and renewing and building partnerships to take us forward.”
Geneva has a history of hosting leading public health and human rights organisations, including international organisations and NGOs central to the HIV response. The city is also home to the ‘Geneva patient’, one of 10 people considered “cured” of HIV.
HIV prevalence in Switzerland is low at 0.2% and new acquisitions have dropped by 20% since 2010, with fewer than 100 AIDS-related deaths in 2023. For more information about IAS 2027, visit www.iasociety.org/conferences/ias2027.